Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer. [electronic resource]
Producer: 20180131Description: 2848-54 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Pancreatic Ductal -- drug therapy
- Deoxycytidine -- analogs & derivatives
- Dexamethasone -- therapeutic use
- Disease-Free Survival
- Female
- Humans
- Hyaluronoglucosaminidase -- adverse effects
- Liver Neoplasms -- secondary
- Lung Neoplasms -- secondary
- Lymphatic Metastasis -- pathology
- Male
- Middle Aged
- Pancreas -- pathology
- Pancreatic Neoplasms -- drug therapy
- Polyethylene Glycols -- chemistry
- Recombinant Proteins -- genetics
- Russia
- Treatment Outcome
- United States
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.